Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23


Stimulation of Retinal Pigment Epithelium With an α7 nAChR Agonist Leads to Müller Glia Dependent Neurogenesis in the Adult Mammalian Retina.

Webster MK, Barnett BJ, Stanchfield ML, Paris JR, Webster SE, Cooley-Themm CA, Levine EM, Otteson DC, Linn CL.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):570-579. doi: 10.1167/iovs.18-25722.


Eye Drops for Delivery of Bioactive Compounds and BrdU to Stimulate Proliferation and Label Mitotically Active Cells in the Adult Rodent Retina.

Linn CL, Webster SE, Webster MK.

Bio Protoc. 2018 Nov 5;8(21). pii: e3076. doi: 10.21769/BioProtoc.3076.


Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.

Webster MK, Cooley-Themm CA, Barnett JD, Bach HB, Vainner JM, Webster SE, Linn CL.

Neuroscience. 2017 Mar 27;346:437-446. doi: 10.1016/j.neuroscience.2017.01.029. Epub 2017 Jan 29.


Neuroprotective Strategies in Glaucoma.

Gossman CA, Christie J, Webster MK, Linn DM, Linn CL.

Curr Pharm Des. 2016;22(14):2178-92. Review.


Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.

Bellus GA, Spector EB, Speiser PW, Weaver CA, Garber AT, Bryke CR, Israel J, Rosengren SS, Webster MK, Donoghue DJ, Francomano CA.

Am J Hum Genet. 2000 Dec;67(6):1411-21. Epub 2000 Oct 27.


A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.

Tavormina PL, Bellus GA, Webster MK, Bamshad MJ, Fraley AE, McIntosh I, Szabo J, Jiang W, Jabs EW, Wilcox WR, Wasmuth JJ, Donoghue DJ, Thompson LM, Francomano CA.

Am J Hum Genet. 1999 Mar;64(3):722-31.


Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.

d'Avis PY, Robertson SC, Meyer AN, Bardwell WM, Webster MK, Donoghue DJ.

Cell Growth Differ. 1998 Jan;9(1):71-8.


Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.

Chen LI, Webster MK, Meyer AN, Donoghue DJ.

J Cell Biol. 1997 May 5;137(3):619-31.


FGFR activation in skeletal disorders: too much of a good thing.

Webster MK, Donoghue DJ.

Trends Genet. 1997 May;13(5):178-82. Review.


Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ.

Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7894-9.


Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.

Meyer AN, Xu YF, Webster MK, Smith AE, Donoghue DJ.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4634-8.


Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.

Goya L, Alexander DB, Webster MK, Kern FG, Guzman RC, Nandi S, Firestone GL.

Cancer Res. 1993 Apr 15;53(8):1816-22.


Noncoordinate expression of Drosophila glue genes: Sgs-4 is expressed at many stages and in two different tissues.

Barnett SW, Flynn K, Webster MK, Beckendorf SK.

Dev Biol. 1990 Aug;140(2):362-73.


Supplemental Content

Loading ...
Support Center